Literature DB >> 22271032

Photodynamic therapy of intraductal papillary mucinous neoplasm.

M Topazian1, N Zhong, T H Baron, S S Vege, K K Wang.   

Abstract

Intraductal papillary mucinous neoplasm (IPMN) of the main pancreatic duct is usually treated by surgical excision of the affected pancreas. Nonoperative ablative therapies have not been described. We treated IPMN of the pancreatic duct with photodynamic therapy (PDT) in a patient who was a poor operative candidate. Porfimer sodium was administered intravenously, and laser light was delivered by a diffusing catheter placed in the pancreatic duct during endoscopic retrograde cholangiopancreatography (ERCP). Imaging and biopsy findings of IPMN resolved after PDT, and symptoms also resolved. Metastatic cancer was diagnosed 2 years after PDT had been initiated. Pancreatic PDT was well tolerated in this case, and may be a therapeutic option for selected patients with IPMN of the main pancreatic duct. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271032     DOI: 10.1055/s-0031-1291539

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  10 in total

Review 1.  [Endoscopic submucosal dissection].

Authors:  J Hochberger; P Köhler; E Kruse; J Hûppertz; M Delvaux; G Gay; E Wedi
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

2.  Effects of integrin-targeted photodynamic therapy on pancreatic carcinoma cell.

Authors:  Min Zhou; Qian-Wen Ni; Shan-Ying Yang; Chun-Ying Qu; Peng-Cheng Zhao; Jian-Cheng Zhang; Lei-Ming Xu
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

3.  Pancreatic cancer-associated Cathepsin E as a drug activator.

Authors:  Wael R Abd-Elgaliel; Zobeida Cruz-Monserrate; Huamin Wang; Craig D Logsdon; Ching-Hsuan Tung
Journal:  J Control Release       Date:  2013-02-26       Impact factor: 9.776

4.  Porfimer-sodium (Photofrin-II) in combination with ionizing radiation inhibits tumor-initiating cell proliferation and improves glioblastoma treatment efficacy.

Authors:  Liat Benayoun; Moshe Schaffer; Rotem Bril; Svetlana Gingis-Velitski; Ehud Segal; Alexsander Nevelsky; Ronit Satchi-Fainaro; Yuval Shaked
Journal:  Cancer Biol Ther       Date:  2012-10-31       Impact factor: 4.742

Review 5.  Photodynamic therapy in gastroenterology.

Authors:  N Shishkova; O Kuznetsova; T Berezov
Journal:  J Gastrointest Cancer       Date:  2013-09

Review 6.  Intraductal papillary mucinous neoplasms of the pancreas: is the puzzle solved?

Authors:  Dharmesh Balsarkar; Shunichi Takahata; Masao Tanaka
Journal:  Indian J Gastroenterol       Date:  2013-03-20

Review 7.  Intraductal papillary mucinous neoplasm of the pancreas: an update.

Authors:  Shu-Yuan Xiao
Journal:  Scientifica (Cairo)       Date:  2012-11-28

8.  An Efficient Photodynamic Therapy Treatment for Human Pancreatic Adenocarcinoma.

Authors:  Alexandre Quilbe; Olivier Moralès; Martha Baydoun; Abhishek Kumar; Rami Mustapha; Takashi Murakami; Bertrand Leroux; Clémentine de Schutter; Elise Thecua; Laurine Ziane; Ludovic Colombeau; Céline Frochot; Serge Mordon; Nadira Delhem
Journal:  J Clin Med       Date:  2020-01-10       Impact factor: 4.241

9.  Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment.

Authors:  Jingjing Lu; Bhaskar Roy; Marlys Anderson; Cadman L Leggett; Michael J Levy; Brian Pogue; Tayyaba Hasan; Kenneth K Wang
Journal:  J Biomed Opt       Date:  2019-11       Impact factor: 3.170

10.  SpyGlass-Guided Photodynamic Therapy for Unresectable Cholangiocarcinoma: A Case Report and Review of the Literature.

Authors:  Jiangjiao Zhou; Li Xiong; Wei Liu; Chun Liu; Chao He; Heng Zou; Yu Wen; Liangwu Lin
Journal:  Front Oncol       Date:  2022-08-10       Impact factor: 5.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.